Tag: MASLD

MRI-derived liver disease markers linked to liver and cardiovascular events

Presented By
Dr Prashant Pandya, Kansas University Medical Center, KS, USA
Conference
DDW 2025
Type
News article

21 May 2025 11:32

Encouraging results for L-carnitine in metabolic dysfunction-associated steatotic liver disease

Presented By
Dr Pezhman Alavinejad, Ahvaz Jundishapur University of Medical Sciences, Iran
Conference
UEGW 2024
Type
Peer-reviewed article

28 November 2024 11:19

Exploring zibotentan plus dapagliflozin for cirrhosis

Presented By
Dr Phil Ambery
Trial
Phase 2, ZENITH-CKD
Conference
UEGW 2024
Type
Peer-reviewed article

28 November 2024 11:19

PsA patients: highest risk of developing NAFLD

Presented By
Mr Anthony Harrison, Leeds Teaching Hospitals NHS Trust, UK
Conference
EULAR 2023
Type
Peer-reviewed article

31 July 2023 06:09

Pemafibrate fails to reduce cardiovascular events in diabetes but may benefit the liver

Presented By
Dr Aruna Pradhan, Brigham and Women’s Hospital, MA, USA
Trial
Phase 3, PROMINENT
Conference
AHA 2022
Type
Peer-reviewed article

11 January 2023 13:46

Normal BMI in NAFLD patients is associated with a higher risk of cardiovascular disease

Presented By
Dr Karn Wijarnpreecha, University of Michigan, MI, USA
Conference
DDW 2022
Type
News article

14 June 2022 22:48

Obeticholic acid prevents liver fibrosis from NASH

Presented By
Dr Isabel Graupera, Institut d'Investigacions Biomediques August Pi I Sunyer, Barcelona, Spain
Trial
Phase 3, REGENERATE
Conference
UEGW 2019
Type
Peer-reviewed article

23 October 2019 16:10

Relationship psoriasis and NAFLD: new data on the hepato-dermal axis

Presented By
Dr Daniel Nieto, La Paz Hospital, Spain
Conference
EADV 2019
Type
Peer-reviewed article

9 October 2019 18:25
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com